RPLP0 and colonic neoplasm: In their study to identify EC genes to monitor enterocyte differentiation and to compare normal and adenocarcinoma of the colon from microarray data, Dydensborg et al [5] recommended RPLP0 for normalising gene quantification in human intestinal epithelial cells and B2M for studying gene expression in human colon cancer.